Casimir
Emmes Group is a global, full-service clinical research organization (CRO) dedicated to advancing health through science, technology, and collaboration. With a history spanning over 47 years, Emmes specializes in designing and managing complex clinical trials across various therapeutic areas, supporting public health initiatives, and integrating innovative technology and AI to improve research efficiency and outcomes. The company serves a diverse range of clients including biopharmaceutical companies, government agencies, non-profits, and academic institutions, with a mission to deliver impactful health solutions worldwide.
Industries
Nr. of Employees
small (1-50)
Casimir
401 N. Washington Street, Suite 700, Rockville, Maryland 20850, United States
Products
Unified eClinical platform
A cloud-based eClinical platform combining EDC, RTSM/IRT, ePRO/eCOA, eConsent, decentralized trial modules and trial traceability tools with AI-assisted build, data ingestion, monitoring and reporting capabilities.
Unified eClinical platform
A cloud-based eClinical platform combining EDC, RTSM/IRT, ePRO/eCOA, eConsent, decentralized trial modules and trial traceability tools with AI-assisted build, data ingestion, monitoring and reporting capabilities.
Services
Full site and patient management services including feasibility, activation, monitoring, recruitment strategies, and study support across phases I–IV.
Protocol-driven data planning, eCRF design, database development, data cleaning, coding, query management, and regulatory-ready deliverables.
Statistical design, adaptive trial methodologies, SAP development, PK/PD analyses, DSMB support, and large-scale omics/ML analytics.
Comprehensive safety services including real-time monitoring, SAE processing and reporting, signal detection, risk management and medical oversight.
Regulatory strategy, document preparation and electronic submission support for drugs, biologics and devices across jurisdictions.
Clinical investigation management, protocol and investigational plan drafting, site monitoring, post-market surveillance and CE marking support including ISO 13485 implementation.
Full site and patient management services including feasibility, activation, monitoring, recruitment strategies, and study support across phases I–IV.
Protocol-driven data planning, eCRF design, database development, data cleaning, coding, query management, and regulatory-ready deliverables.
Statistical design, adaptive trial methodologies, SAP development, PK/PD analyses, DSMB support, and large-scale omics/ML analytics.
Comprehensive safety services including real-time monitoring, SAE processing and reporting, signal detection, risk management and medical oversight.
Regulatory strategy, document preparation and electronic submission support for drugs, biologics and devices across jurisdictions.
Clinical investigation management, protocol and investigational plan drafting, site monitoring, post-market surveillance and CE marking support including ISO 13485 implementation.
Expertise Areas
- Clinical trial management
- Clinical data management
- Biostatistics and statistical design
- Pharmacovigilance and medical monitoring
Key Technologies
- Electronic data capture (EDC)
- RTSM / IRT
- ePRO / eCOA
- eConsent
News & Updates
Press release announcing Germaine Gross as Chief Commercial Officer of Emmes Group.
Press release about Emmes expanding its government research efforts.
Press release about Emmes securing a large contract supporting NIDAS clinical trials.
Article about Emmes' submission of a Duchenne muscular dystrophy assessment plan to the FDA.
Press release about leadership change at Veridix AI.
Press release about the formation of Emmes Group to support its legacy and future growth.
Press release announcing Germaine Gross as Chief Commercial Officer of Emmes Group.
Press release about Emmes expanding its government research efforts.
Press release about Emmes securing a large contract supporting NIDAS clinical trials.
Article about Emmes' submission of a Duchenne muscular dystrophy assessment plan to the FDA.
Press release about leadership change at Veridix AI.
Press release about the formation of Emmes Group to support its legacy and future growth.